Guidance

ARSAC notes for guidance: good clinical practice in nuclear medicine

Guidance on licencing and best use of radiopharmaceuticals and sealed radioactive sources in diagnosis, treatment or research.

Documents

Notes for guidance on the clinical administration of radiopharmaceuticals and use of sealed radioactive sources

This file may not be suitable for users of assistive technology.

Request an accessible format.
If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email arsac@phe.gov.uk. Please tell us what format you need. It will help us if you say what assistive technology you use.

Details

This guidance to good clinical practice for nuclear medicine in the UK is the advice of the Administration of Radioactive Substances Advisory Committee (ARSAC).

These notes update the April 2020 edition to reflect the research application process following the launch of the ARSAC online portal for research.

Published 17 April 2014
Last updated 1 September 2020 + show all updates
  1. Added September 2020 update for Notes for guidance on the clinical administration of radiopharmaceuticals and use of sealed radioactive sources.

  2. Added April 2020 update for Notes for guidance on the clinical administration of radiopharmaceuticals and use of sealed radioactive sources.

  3. Updated 'Notes for guidance on the clinical administration of radiopharmaceuticals and use of sealed radioactive sources'.

  4. Updated notes to clarify the licencing process.

  5. Replaced 'notes for guidance' document and updated detail text.

  6. Uploaded the 2017 edition of guidance.

  7. January 2016 update to guidance.

  8. First published.